Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - Diffusion Pharmaceuticals Inc.Financial_Report.xls
EX-4.6 - EX-4.6 - Diffusion Pharmaceuticals Inc.a15-2678_1ex4d6.htm
EX-4.4 - EX-4.4 - Diffusion Pharmaceuticals Inc.a15-2678_1ex4d4.htm
EX-4.5 - EX-4.5 - Diffusion Pharmaceuticals Inc.a15-2678_1ex4d5.htm
EX-31.1 - EX-31.1 - Diffusion Pharmaceuticals Inc.a15-2678_1ex31d1.htm
EX-32.2 - EX-32.2 - Diffusion Pharmaceuticals Inc.a15-2678_1ex32d2.htm
EX-21.1 - EX-21.1 - Diffusion Pharmaceuticals Inc.a15-2678_1ex21d1.htm
EX-32.1 - EX-32.1 - Diffusion Pharmaceuticals Inc.a15-2678_1ex32d1.htm
EX-10.12 - EX-10.12 - Diffusion Pharmaceuticals Inc.a15-2678_1ex10d12.htm
EX-10.13 - EX-10.13 - Diffusion Pharmaceuticals Inc.a15-2678_1ex10d13.htm
10-K - 10-K - Diffusion Pharmaceuticals Inc.a15-2678_110k.htm
EX-31.2 - EX-31.2 - Diffusion Pharmaceuticals Inc.a15-2678_1ex31d2.htm

Exhibit 10.7

 

 

April 23, 2014

 

Dear Mr. Rubinstein,

 

This letter serves as a formal agreement between RestorGenex (formerly Stratus Media Group) and yourself regarding board of director’s fees earned by you during your service as a director. This will confirm that you have agreed to accept the following sums as all amounts due and owing to you for all service as a board member and employee excluding stock and cash owed to you as director only since January 1, 2014:

 

·                  Cash: $100,000 (to be paid upon the closing of $7.5MM in funding); and

·                  $150,000 (to be paid within 4 months of closing $7.5MM in funding)

·                  Common stock: 1,250 shares

 

Please sign below. Please let me know if you have any questions. Thank you.

 

Sincerely,

 

 

/s/ Tim Boris

 

 

Tim Boris

 

 

General Counsel

 

 

RestorGenex Corporation

 

 

 

 

/s/ Jerold Rubinstein

 

 

Jerold Rubinstein